Amber Heard voices support for Blake Lively amid lawsuit (Entertainment)Syria rebels begin entering Damascus amid calls for political solutionNone
Is Wall Street Bullish or Bearish on Nordson Stock?HETIAN, China , Nov. 30, 2024 /PRNewswire/ -- On November 28 , good news came from Hetian Power Supply Company of State Grid Xinjiang Electric Power Co., Ltd.. Since the official launch of the company's full power outage information perception platform in July 2023 , it has been in stable operation for more than a year and has achieved remarkable results. According to the latest data, the platform has sent more than 74,000 monitoring and warning SMS work orders so far, which has greatly improved the speed of fault recovery and reduced the distribution network failure by more than 60% year-on-year, providing a more reliable guarantee for the safe use of electricity for users in the Hetian area. The company has always been committed to improving the intelligence level of the power grid and ensuring the safety and stability of power supply. By integrating advanced information technology and data analysis means, the platform can realize the perception of full voltage and all types of power outage faults in the entire distribution grid within 30 seconds, which greatly improves the timeliness and accuracy of fault handling processes. In the past year or so, the platform has not only significantly improved the accuracy of fault location, but also made the research and judgment process more efficient and scientific. Operation and maintenance personnel can quickly grasp the fault information and take targeted repair measures, thus greatly shortening the power outage time and reducing the inconvenience and losses to users. SOURCE Hetian Power Supply Company of State Grid Xinjiang Electric Power Co., Ltd
Democrat Bob Casey concedes to Republican David McCormick in Pennsylvania Senate contestIntech Investment Management LLC bought a new position in PTC Therapeutics, Inc. ( NASDAQ:PTCT – Free Report ) in the third quarter, according to its most recent filing with the SEC. The firm bought 18,806 shares of the biopharmaceutical company’s stock, valued at approximately $698,000. A number of other institutional investors also recently bought and sold shares of the stock. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in shares of PTC Therapeutics by 6.0% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 472,288 shares of the biopharmaceutical company’s stock worth $17,522,000 after buying an additional 26,773 shares during the last quarter. Quest Partners LLC increased its position in shares of PTC Therapeutics by 433.9% in the 3rd quarter. Quest Partners LLC now owns 22,359 shares of the biopharmaceutical company’s stock valued at $830,000 after acquiring an additional 18,171 shares during the period. Thrivent Financial for Lutherans purchased a new position in PTC Therapeutics in the 3rd quarter worth $1,450,000. KBC Group NV lifted its position in PTC Therapeutics by 29.2% during the 3rd quarter. KBC Group NV now owns 2,232 shares of the biopharmaceutical company’s stock worth $83,000 after acquiring an additional 504 shares during the period. Finally, Los Angeles Capital Management LLC grew its stake in PTC Therapeutics by 40.0% during the 3rd quarter. Los Angeles Capital Management LLC now owns 15,130 shares of the biopharmaceutical company’s stock valued at $561,000 after purchasing an additional 4,325 shares during the last quarter. Analyst Ratings Changes Several brokerages have recently issued reports on PTCT. Barclays raised their price objective on PTC Therapeutics from $31.00 to $43.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. StockNews.com lowered shares of PTC Therapeutics from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. UBS Group started coverage on shares of PTC Therapeutics in a report on Monday, August 26th. They issued a “buy” rating and a $47.00 price objective on the stock. JPMorgan Chase & Co. raised their target price on shares of PTC Therapeutics from $51.00 to $62.00 and gave the stock an “overweight” rating in a report on Tuesday, November 19th. Finally, Baird R W raised shares of PTC Therapeutics to a “strong-buy” rating in a report on Wednesday, September 4th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, PTC Therapeutics has an average rating of “Hold” and an average price target of $44.69. PTC Therapeutics Stock Down 2.7 % Shares of PTC Therapeutics stock opened at $43.88 on Friday. The firm has a market cap of $3.38 billion, a PE ratio of -7.39 and a beta of 0.63. PTC Therapeutics, Inc. has a twelve month low of $22.47 and a twelve month high of $47.24. The business has a 50-day moving average price of $40.22 and a 200 day moving average price of $36.27. PTC Therapeutics Profile ( Free Report ) PTC Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Further Reading Five stocks we like better than PTC Therapeutics Stock Average Calculator The Latest 13F Filings Are In: See Where Big Money Is Flowing How to Find Undervalued Stocks 3 Penny Stocks Ready to Break Out in 2025 Stock Sentiment Analysis: How it Works FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for PTC Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PTC Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .SHOPPERS are buzzing over a new must-have find from B&M that delivers the glamour of a high-end fragrance at a fraction of the cost. This budget-friendly gift set has sparked excitement for its incredible similarity to a beloved designer scent that usually sells for over £80. 2 A savvy shopper found a £4.99 perfume dupe at B&M Credit: Facebook 2 The bargain product was a dupe for the popular YSL Black Opium, which usually resells for as much as £85 Credit: Yves St Laurent With social media lighting up with glowing reviews, fans are calling it “exactly the same” as the iconic perfume. The £4.99 Scent Favourites Night Orient Pour Femme EDT & Body Wash Gift Set is the perfect way to indulge in luxury without breaking the bank. Many are hailing as a near-perfect dupe for Yves Saint Laurent’s (YSL) coveted Black Opium fragrance. Known for its enchanting blend of pink pepper, orange blossom, coffee, jasmine, and vanilla notes, the scent mirrors the seductive allure of YSL’s iconic Black Opium, which can retail for as much as £85. Read more on dupes BARGAIN BUY Aldi launch £3.99 dupes of luxe beauty brand Jennifer Aniston swears by Wish List Must-have Christmas gifts for her including designer bag dupe that is £365 less The gift set includes a 100ml bottle of Exotic Affair Pour Femme EDT and a 150ml matching body wash, making it a thoughtful and luxurious-feeling gift at an unbeatable price. One savvy shopper, Sarah Russell, took to Facebook to share her discovery, writing: “This smells mmmmm!!! NICE.” Her post quickly gained traction, with fellow fragrance fans chiming in to praise the dupe. “It smells really nice and the same as Black Opium,” one user wrote, while another commented, “Smells the same.” Most read in Money TRUMP UP Donald Trump urged to invest 'fistful of dollars' in late mum's Scottish home LEAVING TOWN High street giant to shut branch as mystery surrounds shopping centre future SHAKE IT UP McDonald's is making a big change to menus in days and customers can't wait CHOC FULL Shoppers rush to buy Cadbury selection boxes at major supermarket for just £1 One nostalgic shopper even remarked, “It reminded me of the 80's Opium.” If you’re looking for a high-end scent without the designer price tag, this could be the ultimate find. 'Dunnes is working their magic again' says fashion fan over Molly Mae cardigan dupe in new colour Better to stock up before it flies off the shelves! It come s as bargain hunters have been quick to share an iconic perfume dupe that could save shoppers nearly £70. Found in B&M for just £3.99, the fan "favourite" eau de toilette "smells exactly the same" as the original. Taking to Facebook, one eagle-eyed shopper posted a picture of the supposed duplicate item that could be perfect for those looking for reasonably priced gifts in the run up to Christmas. Advertised on the B&M website while stocks last, those hoping to nab a bottle of the "elegant" and "romantic" fragrance may want to head to their local store to check shelves. Boasting a "timeless feminine" allure, the Scent Favourites Scandale Femme comes in a 100ml stunning pink bottle shaped like a women's torso. The post has already garnered social media attention with many suggesting the incredible find to be a Jean Paul Gaultier dupe. Featuring the corseted feminine bust-shape, the dupe even seems to have replicated the bottle into a similar form. Read more on the Scottish Sun FERRY WINDY Ferry stranded amid Storm Darragh as passengers stuck on ship for 12 hours HORROR BLAZE Huge fire erupts at Scots industrial estate as emergency crews race to scene The original was created in 1993 and boasts notes of sweet orange, pear and star anise. Currently on sale at Perfume Price for £72.95, it seems to have been discounted from £104, meaning the dupe offers buyers an even greater saving.New Google app feature injects search links into third-party websites
Report: Iowa CB Jermari Harris opts out of rest of seasonSee How Wallace & Gromit: Vengeance Most Fowl Brought Computer Trickery to Classic ClaymationStable housing could have prevented my brother-in-law’s murder
The press has given Prime Minister Paetongtarn Shinawatra the nickname "Paetongphoey" -- a reference to her dependence on prepared scripts at important occasions -- as part of the year-end tradition among Government House reporters to come up with monikers for senior government officials. The nickname "Paetongphoey" is a mash-up between the first two syllables of the prime minister's name, and phoey -- the Thai word for "script". When asked to comment on the name, Ms Paetongtarn insisted it didn't upset her, before adding good-naturedly that "Paetongpad" would have been more accurate, as she reads the scripts off her iPad (as her critics have noted). Government House correspondents also dubbed Ms Paetongtarn's administration as "the dad-backed government", due to her father's -- former prime minister Thaksin -- prominent role in her government. Meanwhile, they also viewed her remarks about her husband's southern origin, brought up when the South was hit by severe floods last month, as quote of the year. In the wake of widespread public criticism for her decision to supervise flood clean-up operations in the North instead of visiting the South when the floods there were at their worst, the premier responded by saying her husband "is a Southerner," so would not let her ignore the area's plight anyway. She said she would have loved to inspect the flooded areas herself, but the widespread nature and timing of the disasters meant she had no option but to delegate tasks to various lawmakers and members of her cabinet. "I feel like I just have to take a step back from anything that makes me feel bad, because hating someone is tiresome," said Ms Paetongtarn at Government House on Monday. When asked about her goals for next year after receiving the feedback from the press, Ms Paetongtarn said she will put her focus on chronic social issues plaguing the country, before pledging to expedite the nation's economic recovery.
I have the fashion sense of an American toad so I’ve never been on the cutting edge of fashion trends. I’ve been wearing essentially the same clothing since the ’90s, my hairstyle hasn’t changed much since I lopped off my long hair in college, and I’ve had a goatee—or some form of one— since Alice in Chains played unplugged on MTV. So it was only last summer, when I was writing some articles for Ink Link about the New Hampshire Fisher Cats , that I started to notice that many of the young men on the team had mustaches—and they didn’t appear to be ironic. Lately, my 19-year-old son has been trying his hand at growing a mustache, and the results have not been good. Like me, he struggles to grow thick facial hair—I barely had to shave until my 20s—and the mustache makes him look like he is the starting center for a middle school basketball team. “You need to shave that,” I said to him last weekend. My son stared down at the floor like he dropped some hair. “I guess you’re right,” he said, defeated. To be honest, I’m not sure how I feel about the resurgence of the mustache. While I’m vehemently opposed to the revival of the mullet— which I shamelessly flaunted long after the trend originally passed —I’m ambivalent about the mustache. We recently started watching “The Good, the Bad, and the Ugly” in the films class that I teach, and there is no denying that the mustaches on Tuco and Angel Eyes (Eli Wallach and Lee Van Cleef) are truly magnificent. Not only do they characterize, but they’re also powerful feats of facial growth. Make no mistake, the robust mustache is a statement. It says, “Here I am, and you need to deal with it.” To be completely honest, a strong mustache can also be intimidating, almost frightening. While I can’t grow one myself, I can admire it. Meanwhile, I’m on the complete opposite end of the spectrum. If I were to shave a mustache and let it grow out, I would look like a guy who should be guessing your weight at a carnival. You see, the chintzy mustache is also a statement. It says, “I’m here, and I’m trying, but it’s just not working.” It has an air of quiet desperation, an emasculating quality. In the end, if you can’t grow a strong mustache, it’s best not to grow one at all. Which might be the only sage advice that I can pass on to my son. Ultimately, the mustache is almost impossible to ignore and not pass judgement, one way or the other. Maybe that’s why it is coming back in style for younger Gen. Z men who grew up on social media and want to be seen because there is no way to be anonymous with a mustache. Even if it is shaved Clark-Gable-pencil-thin, it is a statement. I wrote a poem 1 about mustaches in one of my poetry collections that is now out-of-print, so I’ll share it here. “Men with Mustaches” A man with a mustache must be watched closely, like a storm cloud concealing lightning in its coat. A man with a mustache might be a porn star, a scrawny guy with three legs, sweating pools of sex. A man with a mustache might sell you a used car and promise it will change the way you drive. It will. A man with a mustache might wear his shirt unbuttoned, his chest hair screaming like a room full of fangirls. A man with a mustache might sell tickets for a Ferris wheel and piss behind dunking booths. A man with a mustache might try to write like Hemingway but only succeed in drinking himself to sleep. A man with a mustache might, in fact, be me before I shaved it after scaring myself in the mirror. A man with a mustache must be watched closely; I guarantee he’s looking at you, chewing on a toothpick. Originally published in My Next Bad Decision (Artistically Declined Press, 2014) Warning: There is some NSFW content here. ↩︎
Intech Investment Management LLC Takes Position in PTC Therapeutics, Inc. (NASDAQ:PTCT)